ASLAN Pharmaceuticals Lim...

NASDAQ: ASLN · Real-Time Price · USD
0.60
-0.10 (-14.27%)
At close: Jul 18, 2024, 10:00 PM

ASLAN Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period Ending Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022
Net Income
-45.17M -46.39M -44.52M -25.41M -10.93M
Depreciation & Amortization
-2.37M -2.37M -2.37M -2.37M n/a
Stock-Based Compensation
336.25K 336.25K 336.25K 336.25K n/a
Other Working Capital
103.78M 103.78M 103.78M 103.78M n/a
Other Non-Cash Items
45.17M 46.39M 44.52M 25.41M 10.93M
Deferred Income Tax
-108.51M -108.51M -108.51M -108.51M n/a
Change in Working Capital
104.3M 104.3M 104.3M 104.3M n/a
Operating Cash Flow
-6.24M -6.24M -6.24M -6.24M n/a
Capital Expenditures
n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a
Other Investing Acitivies
-30.21K -30.21K -30.21K -30.21K n/a
Investing Cash Flow
-30.21K -30.21K -30.21K -30.21K n/a
Debt Repayment
n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a
Other Financial Acitivies
9.11M 9.11M 9.11M 9.11M n/a
Financial Cash Flow
9.11M 9.11M 9.11M 9.11M n/a
Net Cash Flow
-16.93M -20.63M -4.08M -4.67M -3.82M
Free Cash Flow
-6.24M -6.24M -6.24M -6.24M n/a